Amneal EVP gifts 80K shares, holds 193K after

Amneal’s Executive Vice President reported gifting 80,000 AMRX shares to a family trust, leaving him with 193,646 directly held shares.

Rhea-AI Filing Summary

Amneal Pharmaceuticals, Inc. (AMRX) insider Andrew S. Boyer, an Executive Vice President, reported a bona fide gift of 80,000 shares of Class A Common Stock on September 1, 2026. The gift was made to a trust for the benefit of certain family members, and Boyer is not the trustee. Following this transfer, he reports 193,646 shares of direct holdings. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

80,000 shares gifted

Gift 1 txn

Insider BOYER ANDREW S

Role Executive Vice President

Type	Security	Shares	Price	Value
Gift	Class A Common Stock F1	80,000	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 193,646 shares (Direct)

Footnotes (1)

1. F1. Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee.

Key Figures

Shares gifted: 80,000 shares Price per share for gift: $0.00 per share Shares held after transaction: 193,646 shares +1 more

4 metrics

Shares gifted 80,000 shares Bona fide gift of Amneal Class A Common Stock on September 1, 2026

Price per share for gift $0.00 per share Reported transaction price for the bona fide gift of 80,000 shares

Shares held after transaction 193,646 shares Direct holdings of Amneal Class A Common Stock reported after the gift

Gift transactions in this filing 1 transaction Single bona fide gift reported by Andrew S. Boyer

Key Terms

bona fide gift, Class A Common Stock, Rule 10b5-1 trading plan, trust

4 terms

bona fide gift financial

"The transaction was reported as a bona fide gift of 80,000 shares"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Class A Common Stock financial

"Gift of 80,000 shares of Class A Common Stock on September 1, 2026"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

trust financial

"Represents a gift to trust for the benefit of certain family members"

A trust is a legal setup in which one party (the trustee) holds and manages assets—like cash, stocks or property—on behalf of other people (beneficiaries) according to instructions from the person who created it (the grantor). Think of it as a locked box with a keyholder who must follow written rules; for investors it matters because trusts influence who controls and benefits from assets, affect taxes and succession, and can change how quickly or transparently shares are bought, sold or voted.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amneal (AMRX) Executive Vice President Andrew S. Boyer report?

He reported a bona fide gift of 80,000 shares of Amneal Class A Common Stock on September 1, 2026, transferring them to a trust for the benefit of certain family members where he does not serve as trustee.

How many AMRX shares does Andrew S. Boyer hold after this reported gift?

After the reported gift, Andrew S. Boyer reports 193,646 shares of Amneal Class A Common Stock held directly. This figure reflects his stake immediately following the September 1, 2026 gift transaction.

Was Andrew S. Boyer’s AMRX stock transfer a sale or a gift?

The transaction was reported as a bona fide gift, not a sale. It involved transferring 80,000 shares of Amneal Class A Common Stock to a trust for certain family members, with a reported price per share of $0.00, consistent with a gift.

Did the AMRX insider transaction involve a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported in connection with this 80,000-share gift of Amneal Class A Common Stock.

Who benefits from the 80,000 AMRX shares gifted by Andrew S. Boyer?

The 80,000 shares of Amneal Class A Common Stock were gifted to a trust for the benefit of certain family members, and Andrew S. Boyer does not serve as trustee of that trust, according to the filing footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:04 PM EDT Accepted by SEC EDGAR 09/02/2026 - 05:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOYER ANDREW S

(Last) (First) (Middle)

C/O AMNEAL PHARMACEUTICALS, INC.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Amneal Pharmaceuticals, Inc. [ AMRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/01/2026		G(1)		80,000	D	$0	193,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee.

Remarks:

	/s/ Denis Butkovic, Attorney-in-Fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)